Quantum Leap Logo with a gradient

Trial Locations

The I-SPY 2 Trial is taking place at about 50 sites across the United States. Check back frequently because new study sites open all the time.

Use this interactive tool to find the I-SPY 2 Trial location nearest to you. This takes you to contact information for the study site so you can get answers to any additional questions you have or express your interest in participating in the study. If there is no Clinical Trial Site near you, consider traveling to participate in the I-SPY 2 Trial.

Click on a state below to view study site contact information

Metastatic trial Locations Map
Oregon California Utah Colorado South Dakota Texas Minnesota Michigan Illinois Ohio Pennsylvania Washington DC New York New Jersey Connecticut Tennessee North Carolina Alabama Georgia Florida

Oregon

Oregon Health and Science University Knight Cancer Institute
Portland, OR 97239
Alexandra Zimmer, MD
trials@ohsu.edu
503-494-1080, 503-494-7999 (appointment)
https://apps.ohsu.edu/research/study-participation-opportunities-system/knight_viewstudy.php?id=IRB00006256 (I-SPY)

California

City of Hope
‍Irvine, CA 92618
Jennifer Tseng, MD
https://www.cityofhope.org/patients
‍800-826-4673

Hoag Family Cancer Institute
Newport Beach, CA 92663
Chaitali Nangia, MD
https://www.hoag.org/contact-us/appointments/

University of California, San Francisco Carol Franc Buck Breast Care Center
San Francisco, CA 94143
Amy Jo Chien, MD
415-353-9579 – New Patient Coordinator
https://clinicaltrials.ucsf.edu/trial/NCT01042379

University of California San Diego Moores Cancer Center
‍La Jolla, CA 92093
Anne Wallace, MD
866-773-2703 (clinic appts must go through clinician to be referred to I-SPY)
‍https://clinicaltrials.ucsd.edu/trial/NCT01042379

University of Southern California Norris Comprehensive Cancer Center
‍Los Angeles CA 90033
Evanthia Roussos Torres, MD, PhD
clinical.trials@med.usc.edu
323-865-0451 (clinical investigation support office)
323-865-3111 (new patient referrals)
https://uscnorris.com/CLTrials/ViewProtocol.aspx?protocol_num=1B-10-3&protocol_id=2497

University of California, Davis Comprehensive Cancer Center
‍Davis, CA 95817Mili Arora, MD
916-734-5959 or 800-770-9261 (new patient referral)
916-734-3604 (clinical trials info)
Teri Nguyen (coordinator) 916-734-8266

Utah

University of Utah, Huntsman Cancer Institute
Salt Lake City, Utah, 84112
Christos Vaklavas, MD
1-888-424-2100 (cancer learning center, will direct to CRCs)
https://healthcare.utah.edu/huntsmancancerinstitute/clinical-trials/trial.php?id=27388&no=137669

Colorado

University of Colorado Cancer Center
Aurora, CO 80045
Virginia Borges, MD
researchstudies@cuanschutz.edu
720-848-0408 (breast cancer clinic)

South Dakota

Sanford Clinical Research
Sioux Falls, SD, 57104
Amy Sanford, MD
605-328-8000
605-328-1368

Texas

Coming Soon

Mays Cancer Center
San Antonio, TX

Minnesota

University of Minnesota Masonic Cancer Center
Minneapolis, MN, 55455
Douglas Yee, MD
ccinfo@umn.edu
612-624-2620 – Nurse Navigator Line for more info on clinical trials that may be available to you
612-676-4200 – Breast Cancer Clinic appointments
https://clinicaltrial.cancer.umn.edu/sip/#

Mayo Clinic Breast Cancer Center–Rochester
Rochester, MN 55905
Judy C. Boughey, MD
855-776-0015
https://www.mayo.edu/research/clinical-trials/cls-20116766#eligibility
https://www.mayo.edu/research/forms/cancer-clinical-trials?pocid=CLS-20116766&nctid=NCT01042379&epicenterid=E10014713

Michigan

Sparrow
Lansing, MI 48192
Brittani Thomas, MD
1.800.Sparrow (1.800.772.7769)
https://www.sparrow.org/departments-conditions/all-departments/cancer-care-oncology

Illinois

Loyola University Cardinal Bernardin Cancer Center
Maywood, IL 60153
Kathy S. Albain, MD
mbartolotta@luc.edu
888-584-7888
https://loyolamedicine.org/cancer/breast-cancer (to make an appointment)

University of Chicago Medical Center
Chicago, IL 60437
Rita Nanda, MD
cancerclinicaltrials@bsd.uchicago.edu
1-855-702-8222
https://www.uchicagomedicine.org/find-a-clinical-trial/clinical-trial/6/10183b

Ohio

Cleveland Clinic Taussig Cancer Center
Cleveland, OH 44106
Erin Roesch, MD
800-233-2273
https://my.clevelandclinic.org/clinical-trials/1485-i-spy-2-trial—investigation-of-serial-studies-to-predict-your-therapeutic-response-with-imaging-and-molecular-analysis-2

Ohio State University Comprehensive Cancer Center-The James
Columbus, OH 43210
Nicole Williams, MD
herohelpline@osu.edu (clinical trial help email)
614-293-4376 (HERO) – inquire about cancer clinical trials
614-293-5066 or toll-free at 800-293-5066 to make an appointment

Pennsylvania

University of Pennsylvania Abramson Cancer Center
Philadelphia, PA 19104
Amy Clark, MD, MSCE
1-855-216-0098
https://app.emergingmed.com/acc-upenn/trial/46485/

Washington DC

Georgetown University Lombardi Cancer Center
Washington, DC 20007
Claudine Isaacs, MD
202-444-2223 (make an appointment)
https://lombardi.georgetown.edu/patient/info/schedule/# (make an appointment)

New York

Colombia Herbert Irving Comprehensive Cancer Center
New York, New York
Meghna Trivedi, MD
cancerclinicaltrials@cumc.columbia.edu
212-305-5098 (new patient navigation line)
212-342-5162 (clinical trial navigator line)
https://recruit.cumc.columbia.edu/clinical_trial/1371
https://cumc.co1.qualtrics.com/jfe/form/SV_est8ZlfAcxfnnyB (New Patient Form)

University of Rochester Medicine Wilmot Cancer Institute
Rochester, NY 14642
Carla Falkson, MD
1-866-494-5668 (4WILMOT)
Email: WCICTOResearch@urmc.rochester.edu

New Jersey

Rutgers Cancer Institute of New Jersey
New Brunswick, NJ 08901
Coral Omene MD
732-235-7356
https://cinj.org/clinical-trials/find-clinical-trial?show=trial&p=042102

Rutgers Saint Barnabas Medical Center
Livingston NJ, 07039
(973) 322-5000

Rutgers Robert Wood Johnson University Hospital Somerset
Somerville, NJ 08876
732-235-7356 or 844-CANCERNJ

Connecticut

Yale Medical Center
New Haven, CT 05620
Mariya Rozenblit, MD
helpusdiscover@yale.edu
203-200-2328 (breast center)
877-978-8343 (clinical trials)

Tennessee

Vanderbilt-Ingram Cancer Center
Nashville, TN 27204
Ingrid Mayer, MD
1-800-811-8480 (learn about clinical trials)
615-936-8422
https://www.vicc.org/clinical-trials/protocol-viccbre1951

North Carolina

Wake Forest Baptist Health Comprehensive Cancer Center
Winston-Salem, NC 27157
Alexandra Thomas, MD, FACP
btopalog@wakehealth.edu
1-833-206-1202 (clinical trials)
336-716-0248 (ISPY)
336-716-WAKE (9253)
888-716-9253 (toll-free) (appointments)
https://www1.wakehealth.edu/beinvolved/eng/studies/IRB00053064

Alabama

University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, AL 35294
Erica Stringer-Reasor
205-801-9034 (make an appointment with cancer center)
https://www.uabmedicine.org/appointment-cancer (appointment)

Georgia

Emory University Winship Cancer Institute
Atlanta, GA 30322
Kevin Kalinsky, MD, MS
winshipcto@emory.edu
https://winshipcancer.emory.edu/patient-care/being-a-patient/index.html (to request an appointment)
404-778-1868
404-778-PINK (778-7465) to request an appointment

Coming Soon
Emory St Joseph’s
Atlanta, GA 30342

Florida

Moffitt Cancer Center
Tampa, FL 33612
Heather Han, MD
813-745-6100 or 1-800-679-0775 (clinical trial numbers)
1-888-663-3488 (make an appointment)
https://moffitt.org/patient-family/preparing-for-your-appointment/scheduling-your-appointment/ (make an appointment)

Consider traveling to an I-SPY Trial

If there is no Clinical Trial Site near you, consider traveling to participate in the I-SPY 2 Trial. Listen to Barri discuss why she decided to travel to an I-SPY 2 Clinical Trial site to participate.

Need financial assistance?

If you are interested in participating in the I-SPY 2 Trial and need financial travel assistance or financial support for other clinical trial-related costs, these resources may be able to offer help.

Dictionary of Cancer Terms

Find easy-to-understand definitions of terms related to cancer and medicine.

Go to Dictionary
© Quantum Leap Healthcare Collaborative. 2023-2024.

For Patients

For Investigators

Partnerships

About us

Trials
Resources
Contact Us

For Patients

For Investigators

Partnerships

About us

Studies
Collaborations
Publications
Contact Us
Donate
Investigators Portal

For Patients

For Investigators

Partnerships

About us

Partnerships
One Source
Donate

For Patients

For Investigators

Partnerships

About us

Our Approach
QLHC in the News
Working at QLHC
Contact Us
Donate

Tracey Heather

Advocate Liaison

As Patient Engagement Lead at Quantum Leap, I manage follow-up data projects for the I-SPY 2 Trial, develop strategies to strengthen patient engagement, and oversee the I-SPY Advocate group. After six successful years raising funds to support Quantum’s mission, I embraced this new role last summer, drawn by the opportunity to make a direct impact on the patients we serve. Each day brings new challenges and insights, and I especially enjoy supporting and collaborating with our inspiring I-SPY Advocates.

Outside of work, I am pursuing a Master of Public Administration with a focus on nonprofit management at SF State. I’m passionate about trail running, skiing, live music, camping, traveling, and collegiate gymnastics—my daughter competes at Oregon State. For the past 5 years, I have volunteered with SF CASA as a mentor to an incredible 18-year-old foster youth whose resilience continually reminds me of life’s true priorities.

Carolyn Clark Beedle

Carolyn Clark Beedle, a 2023 breast cancer survivor, joined the advocate program after successful completion of treatment with the UCSF Breast Oncology Program. Her experience working with a patient advocate during her TNBC treatment led to an understanding that empowering women to advocate for their own health and healthcare will contribute to improved health outcomes and broader access to care. Carolyn began advocating for cancer patients and their families during her treatment, now is a member of the Breast Science Advocacy Core (BSAC) with the UCSF Breast Oncology Program, and currently shares information and research with CFNP associates at La Clinica in the Bay Area to inform and empower their patient population.

Carolyn is continuing her on the ground training as an advocate reviewer with both Quantum Health and BSAC and is enrolled in the Patient Advocacy Training in Health Science course with Stanford Medicine. Her 30+ career in corporate marketing/communications, program development and non-profit leadership augmented by her breast cancer treatment experience serves Carolyn well in representing and communicating the patient voice and perspective.

She received her BA (History/English Lit) and MA (Public History/Research and Record Management) from the University of San Diego, is a proud fifth generation San Franciscan, and active board member with numerous non-profits that support social work and the arts.

Silver Alkhafaji

Silver Alkhafaji is a PhD candidate in the Pharmaceutical Sciences and Pharmacogenomics (PSPG) program at UCSF. She received her Bachelor of Science in Chemical Biology from UC Berkeley. Prior to UCSF, she worked in the Clinical Pharmacology Department at Genentech. Silver’s current research focuses on non-invasive liquid biopsies to predict response and side effects of immunotherapies and endocrine therapies in early-stage breast cancer participants in I-SPY 2.

Silver is interested in clinical outcomes research to advance precision medicine and improve cancer patients’ quality of life. She is passionate about health equity, inclusive research, patient advocacy, and women’s health.
Silver volunteers at the Patient and Family Cancer Support Center at UCSF where she assists in patient navigation and connecting patients and their families with resources that improve their healthcare experience while receiving cancer treatments and/or during survivorship. 

Through her DEI work in her PhD program, Silver raises awareness around issues related to social justice and community building through organizing community-centered events. Additionally, she is a member of the Life Sciences Career Advisory Council at Thrive Scholars, where she enjoys supporting college students of color from economically disadvantaged communities in providing the opportunities they need to thrive at top colleges and in high-trajectory careers. 

Silver is a member of the American Association of University Women (AAUW) Alameda Branch where she focuses her efforts on increasing membership of community college women coming from exceptional backgrounds: student parents, low-income, and first-generation college students.

In her free time, she writes poetry and prose on emotional healing, radical acceptance, and patience. Writing has helped her process difficult situations and connect with people on a deeper level.

Jane Mortimer

Jane is a breast cancer survivor and advocate dedicated to positively impacting the lives of women affected by the disease. Diagnosed with triple negative breast cancer in 2012, she participated in the I-SPY 2 trial at UCSF and has been cancer free for more than ten years.

Her advocacy journey began in 2003 at UCSF as a volunteer with the Patient and Family Cancer Support Center and Decision Support Services and she previously managed the Peer Support program at UCSF. Drawing on her experience in marketing and media strategy, she uses her skills to make a meaningful impact by supporting advocacy and research that improves outcomes for women living with breast cancer.

Jan Tomlinson

In March of 2023 , Jan was diagnosed with a large aggressive triple negative breast cancer and informed that her cancer was the” bad girl” of cancer and offered standard chemotherapy for 24 weeks. Devasted by the diagnosis Jan felt like she had a dire prognosis. After seeking several opinions, she opted to join a Clinical Trial program for her treatment. The trial consisted of significantly less chemotherapy, and monitored closely over a 12-week period, The data predicted a complete pathological response , and she then went immediately to surgery. Pathology reports supported that she had a successful outcome reaching PCR meaning the tumor was gone, and no residual cancer was found in the surrounding tissue or lymph nodes. Jan was thrilled when her surgeon advised her of the results. The experience made Jan want to give back and share information that she received when she was at a critical juncture in her diagnosis. She is so passionate about making sure that everyone knows that the standard of care is one treatment option.

As she says, “ clinical trials have to be on the table” Because she achieved PCR, she expects a great outcome. She wants to share her story and encourage other women to strongly consider and participate in clinical trials. Jan is a UCSF Patient Advocate, involved in several programs they lead. Jan also is a BLACC Cab Member. Jan recently was in Washington DC to participate on a panel on Clinical Trials for ISPY at the National Press Club. UCSF will be hosting the RISE Up For Breast Cancer event where Jan will share her experience with clinical trials.

Deborah Collyar

Deb is a connector who founded Patient Advocates in Research (PAIR) “where research meets reality,” bringing ideas and people together for medical advances that offer real results for diverse patients and families.

Her vast experience between the worlds of tech, communication, strategy, management, policy, and equity bridges gaps between patients, scientists, medical providers, payers, governments, and non-profits.

Deb infuses patient engagement into projects, gathers relevant patient input, and encompasses many diseases, programs and policies at grassroots, national and international levels through companies, academia, and governments.

Key patient insights are delivered throughout discovery, development, clinical trials, results reporting, data-sharing, standards, genomics, and into practice.

Her experience spans translational and clinical research, epidemiology, health outcomes, and health delivery research with academia, federal agencies, companies, and patient communities.